Skip to main content

Advertisement

Table 3 Number of adverse events within 90 days after primary total hip replacement (THR) among propensity score matched patients who were eligible for red blood cell transfusion.

From: Allogeneic blood transfusion and prognosis following total hip replacement: a population-based follow up study

  Propensity score matching model
Outcome Transfusion
n = 2,254
Non-transfusion
n = 2,254
Death 39 (1.7%) 18 (0.8%)
Cardiovascular or cerebrovascular disease 54 (2.4%) 39 (1.7%)
Deep venous thrombosis and/or pulmonary embolism 28 (1.2%) 23 (1.0%)
Pneumonia 36 (1.6%) 17 (0.8%)
Reoperation due to Infection of THR 5 (0.2%) 5 (0.2%)